LEAPER Trademark

Trademark Overview

On Tuesday, September 18, 2018, a trademark application was filed for LEAPER with the United States Patent and Trademark Office. The USPTO has given the LEAPER trademark a serial number of 88122459. The federal status of this trademark filing is REGISTERED as of Tuesday, September 13, 2022. This trademark is owned by EDIGENE INC. The LEAPER trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Medical and scientific research in the field of genome editing, gene editing, genome engineering, gene modulation, transcriptional regulation, transcriptional modulation, genetic diseases, gene therapy and cell therapy; medical and scientific research information in the field of genome editing, gene editing, genome engineering, gene modulation, transcriptional regulation, transcriptional modulation, genetic diseases, gene therapy and cell therapy; pharmaceutical research and development; pharmaceutical research services; providing medical and scientific research information in the fields of pharmaceuticals and genetics
leaper

General Information

Serial Number88122459
Word MarkLEAPER
Filing DateTuesday, September 18, 2018
Status700 - REGISTERED
Status DateTuesday, September 13, 2022
Registration Number6846885
Registration DateTuesday, September 13, 2022
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 3, 2019

Trademark Statements

Goods and ServicesMedical and scientific research in the field of genome editing, gene editing, genome engineering, gene modulation, transcriptional regulation, transcriptional modulation, genetic diseases, gene therapy and cell therapy; medical and scientific research information in the field of genome editing, gene editing, genome engineering, gene modulation, transcriptional regulation, transcriptional modulation, genetic diseases, gene therapy and cell therapy; pharmaceutical research and development; pharmaceutical research services; providing medical and scientific research information in the fields of pharmaceuticals and genetics

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, September 25, 2018
Primary Code042
First Use Anywhere DateThursday, September 24, 2020
First Use In Commerce DateThursday, September 24, 2020

Trademark Owner History

Party NameEDIGENE INC
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressBEIJING 102206
CN
Party NameEDIGENE INC
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBEIJING 102206
CN
Party NameEDIGENE INC
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBEIJING 102206
CN

Trademark Events

Event DateEvent Description
Tuesday, September 13, 2022NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, September 13, 2022REGISTERED-PRINCIPAL REGISTER
Friday, August 12, 2022NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Thursday, August 11, 2022ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, August 3, 2022STATEMENT OF USE PROCESSING COMPLETE
Thursday, July 28, 2022USE AMENDMENT FILED
Thursday, July 28, 2022TEAS STATEMENT OF USE RECEIVED
Saturday, October 30, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, October 28, 2021SOU EXTENSION 4 GRANTED
Thursday, October 28, 2021SOU EXTENSION 4 FILED
Thursday, October 28, 2021TEAS EXTENSION RECEIVED
Friday, June 25, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, June 23, 2021SOU EXTENSION 3 GRANTED
Wednesday, June 23, 2021SOU EXTENSION 3 FILED
Wednesday, June 23, 2021TEAS EXTENSION RECEIVED
Wednesday, January 6, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, January 4, 2021SOU EXTENSION 2 GRANTED
Monday, January 4, 2021SOU EXTENSION 2 FILED
Monday, January 4, 2021TEAS EXTENSION RECEIVED
Tuesday, July 21, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, July 17, 2020SOU EXTENSION 1 GRANTED
Friday, July 17, 2020SOU EXTENSION 1 FILED
Friday, July 17, 2020TEAS EXTENSION RECEIVED
Friday, April 3, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, April 3, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, March 10, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, March 10, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, March 10, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, March 10, 2020TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Tuesday, January 28, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 3, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 3, 2019PUBLISHED FOR OPPOSITION
Wednesday, November 13, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, October 30, 2019ASSIGNED TO LIE
Thursday, October 24, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, October 9, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, October 8, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, October 8, 2019TEAS REQUEST FOR RECONSIDERATION RECEIVED
Tuesday, June 11, 2019NOTIFICATION OF FINAL REFUSAL EMAILED
Tuesday, June 11, 2019FINAL REFUSAL E-MAILED
Tuesday, June 11, 2019FINAL REFUSAL WRITTEN
Monday, May 20, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Saturday, May 18, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Saturday, May 18, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sunday, March 10, 2019TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, December 10, 2018NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, December 10, 2018NON-FINAL ACTION E-MAILED
Monday, December 10, 2018NON-FINAL ACTION WRITTEN
Tuesday, December 4, 2018ASSIGNED TO EXAMINER
Tuesday, September 25, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, September 21, 2018NEW APPLICATION ENTERED IN TRAM

Related Keywords

leaper gene research transcriptional modulation therapy editing genome scientific medical cell